April 24, 2020 / 4:00 AM / a month ago

Japan's Takeda plans to sell consumer health unit for around $3.7 bln - Nikkei

TOKYO, April 24 (Reuters) - Japan’s Takeda Pharmaceutical Co Ltd plans to sell its consumer health unit for around 400 billion yen ($3.72 billion), Nikkei Business reported.

Possible buyers of the unit include Taisho Pharmaceutical Co. and large investment funds, Nikkei reported. A Takeda spokeswoman said the company does not comment on rumours.

Following its acquisition of Shire Plc in 2019 for $59 billion, Takeda has pledged to dispose of $10 billion worth of non-core assets to pare down debt. ($1 = 107.6500 yen) (Reporting by Rocky Swift; Editing by Muralikumar Anantharaman)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below